Array
(
[id] => 1130
[catid] => 203
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1130.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that routine and combined measurement of pre- and postoperative cardiac troponins may be used to help evaluate the risk of some adverse outcomes after non-cardiac surgery. Level of evidence: Moderate；Recommendation grade:Weak.
[laiyuan] => 我们建议常规或联合测定术前和术后的心肌肌钙蛋白可能有助于评估非心脏手术后一些不良结局的风险。（证据等级：中等；推荐强度：弱推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议常规或联合测定术前和术后的心肌肌钙蛋白可能有助于评估非心脏手术后一些不良结局的风险。（证据等级：中等；推荐强度：弱推荐）
We suggest that routine and combined measurement of pre- and postoperative cardiac troponins may be used to help evaluate the risk of some adverse outcomes after non-cardiac surgery. Level of evidence: Moderate；Recommendation grade:Weak.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1131
[catid] => 203
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1131.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => Routine combined pre- and postoperative measurement of cardiac troponins in addition to clinical risk scores may be considered for the prediction of some postoperative events. Level of evidence:Very low；Recommendation grade:Weak.
[laiyuan] => 除临床风险评分外，常规术前和术后联合测量心肌肌钙蛋白可用于预测一些术后事件。（证据等级：很低；推荐强度：弱推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
除临床风险评分外，常规术前和术后联合测量心肌肌钙蛋白可用于预测一些术后事件。（证据等级：很低；推荐强度：弱推荐）
Routine combined pre- and postoperative measurement of cardiac troponins in addition to clinical risk scores may be considered for the prediction of some postoperative events. Level of evidence:Very low；Recommendation grade:Weak.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1132
[catid] => 203
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1132.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that routine measurement postoperative cardiac troponins may be used to evaluate the risk of adverse outcomes after non-cardiac surgery. The higher the concentration, the higher the risk of 30-day mortality.Level of evidence: Moderate；Recommendation grade:Weak.
[laiyuan] => 我们建议术后常规测量心肌肌钙蛋白可用于评估非心脏手术后不良后果的风险。浓度越高，30天死亡率越高。（证据等级：中等；推荐强度：弱推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议术后常规测量心肌肌钙蛋白可用于评估非心脏手术后不良后果的风险。浓度越高，30天死亡率越高。（证据等级：中等；推荐强度：弱推荐）
We suggest that routine measurement postoperative cardiac troponins may be used to evaluate the risk of adverse outcomes after non-cardiac surgery. The higher the concentration, the higher the risk of 30-day mortality.Level of evidence: Moderate；Recommendation grade:Weak.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1133
[catid] => 203
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1133.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that routine measurement of postoperative cardiac troponins may be used for the prediction of some postoperative outcomes, in particular 30-day all-cause mortality. Level of evidence: Low；Recommendation grade:Weak.
[laiyuan] => 我们建议常规测量术后心肌肌钙蛋白可用于预测一些术后结果，特别是30天的全因死亡率。（证据等级：低；推荐强度：弱推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议常规测量术后心肌肌钙蛋白可用于预测一些术后结果，特别是30天的全因死亡率。（证据等级：低；推荐强度：弱推荐）
We suggest that routine measurement of postoperative cardiac troponins may be used for the prediction of some postoperative outcomes, in particular 30-day all-cause mortality. Level of evidence: Low；Recommendation grade:Weak.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1134
[catid] => 203
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1134.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => The routine measurement of postoperative cardiac troponins within a biomarker-enhanced management program to improve outcome should only be used in the context of clinical research.Level of evidence: Very low；Recommendation grade:No recommendation.
[laiyuan] => 常规的术后心肌肌钙蛋白测量在生物标记物增强管理计划中，以改善结果应仅用于临床研究。（证据等级：很低；推荐强度：不推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
常规的术后心肌肌钙蛋白测量在生物标记物增强管理计划中，以改善结果应仅用于临床研究。（证据等级：很低；推荐强度：不推荐）
The routine measurement of postoperative cardiac troponins within a biomarker-enhanced management program to improve outcome should only be used in the context of clinical research.Level of evidence: Very low；Recommendation grade:No recommendation.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1135
[catid] => 192
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1135.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that routine measurement of preoperative B-type natriuretic peptides may be used to help evaluate the risk of some adverse outcomes in non-cardiac surgery. Level of evidence: Moderate；Recommendation grade:Weak.
[laiyuan] => 我们建议术前常规测定B型钠尿肽可能有助于评估非心脏手术中某些不良结局的风险。（证据等级：中等；推荐强度：弱推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议术前常规测定B型钠尿肽可能有助于评估非心脏手术中某些不良结局的风险。（证据等级：中等；推荐强度：弱推荐）
We suggest that routine measurement of preoperative B-type natriuretic peptides may be used to help evaluate the risk of some adverse outcomes in non-cardiac surgery. Level of evidence: Moderate；Recommendation grade:Weak.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1136
[catid] => 192
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1136.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that the addition of preoperative B-type natriuretic peptides to clinical risk scores might be used to improve the prediction of some postoperative events, in particular 30-day major adverse cardiac events. Level of evidence: Very low；Recommendation grade:Weak.
[laiyuan] => 我们建议将术前b型利钠肽添加到临床风险评分中，可以用于改善一些术后事件的预测，特别是30天的主要不良心脏事件。（证据等级：很低；推荐强度：弱推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议将术前b型利钠肽添加到临床风险评分中，可以用于改善一些术后事件的预测，特别是30天的主要不良心脏事件。（证据等级：很低；推荐强度：弱推荐）
We suggest that the addition of preoperative B-type natriuretic peptides to clinical risk scores might be used to improve the prediction of some postoperative events, in particular 30-day major adverse cardiac events. Level of evidence: Very low；Recommendation grade:Weak.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1137
[catid] => 191
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1137.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => The use of preoperative BNP/NT-proBNP-enhanced management to improve outcomes should be limited to the context of clinical research. Level of evidence: No data；Recommendation grade:No recommendation.
[laiyuan] => 术前BNP/NT-proBNP强化管理的使用应限于临床研究的背景下。（证据等级：无数据；推荐强度：不推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前BNP/NT-proBNP强化管理的使用应限于临床研究的背景下。（证据等级：无数据；推荐强度：不推荐）
The use of preoperative BNP/NT-proBNP-enhanced management to improve outcomes should be limited to the context of clinical research. Level of evidence: No data；Recommendation grade:No recommendation.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1138
[catid] => 203
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1138.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => Routine measurement of postoperative BNP/NT-proBNP to help evaluate the risk of adverse outcomes should only be used in the context of clinical research. Level of evidence:Very low；Recommendation grade:No recommendation.
[laiyuan] => 常规测量术后BNP/NT-proBNP以帮助评估不良后果的风险，只能在临床研究中使用。（证据等级：很低；推荐强度：不推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
常规测量术后BNP/NT-proBNP以帮助评估不良后果的风险，只能在临床研究中使用。（证据等级：很低；推荐强度：不推荐）
Routine measurement of postoperative BNP/NT-proBNP to help evaluate the risk of adverse outcomes should only be used in the context of clinical research. Level of evidence:Very low；Recommendation grade:No recommendation.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
Array
(
[id] => 1139
[catid] => 191
[title] => ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1139.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:23:33
[updatetime] => 2024-01-11 15:23:33
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://guide.medlive.cn/guideline/28939
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => ESAIC
[pdf] =>
[tjyjyw] =>
[lyyw] => The routine addition of BNP/NT-proBNP to clinical risk scores to improve the prediction of postoperative events should only be used in the context of clinical research. Level of evidence:Very low；Recommendation grade:No recommendation.
[laiyuan] => 常规在临床风险评分中加入BNP/NT-proBNP以提高对术后事件的预测，这种方法只能在临床研究的背景下使用。（证据等级：很低；推荐强度：不推荐）
[znzldj] => A
[_inputtime] => 1704957813
[_updatetime] => 1704957813
[_nrjc] =>
[_nrsh] =>
)
推荐意见
常规在临床风险评分中加入BNP/NT-proBNP以提高对术后事件的预测，这种方法只能在临床研究的背景下使用。（证据等级：很低；推荐强度：不推荐）
The routine addition of BNP/NT-proBNP to clinical risk scores to improve the prediction of postoperative events should only be used in the context of clinical research. Level of evidence:Very low；Recommendation grade:No recommendation.
证据评价方法：GRADE
指南质量等级：A
年份：2023
国家：ESAIC
